Skip navigation
Please use this identifier to cite or link to this item: http://repositorio2.unb.br/jspui/handle/10482/44950
Files in This Item:
There are no files associated with this item.
Title: Downregulation of histone methyltransferase EHMT2 in CD4+ T-cells may protect HTLV-1-infected individuals against HAM/TSP development
Authors: Colaço, Camila Schoueri
Matos, Adriano Reis de
Estrêla, Martha Silva
Rocha Júnior, Maurício Cristiano
Otaguiri, Kátia Kaori
Rodrigues, Evandra Strazza
Takayanagui, Osvaldo Massaiti
Covas, Dimas Tadeu
Kashima, Simone
Pittella-Silva, Fabio
Haddad, Rodrigo
metadata.dc.contributor.affiliation: Universidade de Brasília, Faculdade de Ciências da Saúde, Laboratório de Patologia Molecular do Câncer
Universidade de Brasília, Faculdade de Ciências da Saúde, Laboratório de Patologia Molecular do Câncer
Universidade de Brasília, Faculdade de Ciências da Saúde, Laboratório de Patologia Molecular do Câncer
Universidade de São Paulo, Centro de Hemoterapia de Ribeirão Preto
Universidade de São Paulo, Centro de Hemoterapia de Ribeirão Preto
Universidade de São Paulo, Centro de Hemoterapia de Ribeirão Preto
Universidade de São Paulo, Centro de Hemoterapia de Ribeirão Preto
Universidade de São Paulo, Centro de Hemoterapia de Ribeirão Preto
Universidade de São Paulo, Centro de Hemoterapia de Ribeirão Preto
Universidade de Brasília, Faculdade de Ciências da Saúde, Laboratório de Patologia Molecular do Câncer
Universidade de Brasília, Faculdade de Ciências da Saúde, Laboratório de Patologia Molecular do Câncer
Assunto:: Vírus da leucemia
Mielopatia
Histonas
Metiltransferases
Issue Date: 12-Jun-2017
Publisher: Springer
Citation: COLAÇO, Camila Schoueri et al. Downregulation of histone methyltransferase EHMT2 in CD4+ T-cells may protect HTLV-1-infected individuals against HAM/TSP development. Archives of Virology, v. 162, p. 3131-3136, 2017. DOI: https://doi.org/10.1007/s00705-017-3428-8.
Abstract: Approximately 5% of human T-cell leukemia virus type 1 (HTLV-1)-infected individuals will develop one of the HTLV-1-related diseases, such as HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) or adult T-cell leukemia. However, the mechanisms responsible for the appearance of symptoms have not been fully clarified. It is believed that viral factors, host genetic and epigenetic mechanisms are implicated in this process. Studies have shown the involvement of histone methyltransferases in retrovirus infection, but no study observed their expression in HTLV-1-infected patients. Among them, euchromatic histone-lysine N-methyltransferase (EHMT)-1 and EHMT-2 were related to retroviral latency in HIV-1 infection. We investigated whether histone methyltransferases EHMT1 and EHMT2 exert any influence on HAM/TSP development by assessing their expression levels in CD4+ T-cells from HTLV–1–infected patients. CD4+ T-cells were immunomagnetically isolated from peripheral blood mononuclear cells of HTLV-1-infected or non–infected individuals and the expression levels of EHMT1 and EHMT2 were determined by RT-qPCR. We observed that EHMT2 was negatively regulated in HTLV-1 asymptomatic carriers compared to non-infected individuals. No difference was observed for EHMT1. These results suggest that EHMT2 downregulation in CD4+ T-cells may be linked to a protection mechanism against the development of HAM/TSP.
DOI: https://doi.org/10.1007/s00705-017-3428-8
metadata.dc.relation.publisherversion: https://link.springer.com/article/10.1007/s00705-017-3428-8
Appears in Collections:Artigos publicados em periódicos e afins

Show full item record " class="statisticsLink btn btn-primary" href="/jspui/handle/10482/44950/statistics">



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.